Manufacturing

Pharmaceutical Outsourcing Manufacturing

Contract development and manufacturing companies, or CDMOs, provide a wide range of drug development, formulation and manufacturing services to companies that need outsourcing help to bring pharmaceutical products to market.

Full-service contract development and manufacturing companies can take on every aspect of drug development and manufacturing – many can develop a variety of dosage forms. Specialized CDMOs typically concentrate on one kind of dosage form.

Services offered by contract manufacturing organizations typically include, but are not limited to:

Formulation
Analytical Services
Blending
Coating
Tableting
Parenteral Product R&D and Manufacturing
Aseptic Filling
Unit Dose Semi-Solids

Transdermal Product Development and Manufacturing
Topicals
Converting
Packaging
Serialization
Shipment

Filter

Hide Filter

Penn Pharma Announces £14 Million Pound Investment
Tuesday, February 28, 2012
Global pharmaceutical manufacturer and developer, Penn Pharma, has today [28 February 2012] announced a £14 million investment in its South Wales UK facility to strengthen its offering for international supply and further build on the company’s ... read more
Almac Boosts Capacity and Productivity
Tuesday, February 28, 2012
Almac, a leading provider of contract services to the global Pharmaceutical and Biotech industries, has addressed a surge in clinical outsourcing by acquiring two new pieces of encapsulation equipment at their North American headquarters in Souderton... read more
INC Research to Discuss Global Partnerships and Future Trends
Tuesday, February 28, 2012
INC Research, LLC, a therapeutically focused clinical research organization (CRO) with a Trusted Process® for delivering reliable results, will discuss the evolution of clinical development outsourcing trends at the Partnerships(TM) in Clinical ... read more
EMD Millipore Partners with Charles River Laboratories
Monday, February 27, 2012
EMD Millipore, the Life Science division of Merck KGaA of Darmstadt, Germany, today announced it will be partnering with Charles River Laboratories International, Inc. of Wilmington, MA, to exclusively license EMD Millipore's TrueSpike™ technology. ... read more
CTD Holdings, Inc. - NanoSonic Products Division Signs Manufacturing Agreement With Florida Biologix
Wednesday, February 22, 2012
NanoSonic Products, Inc., a wholly owned subsidiary of CTD Holdings, Inc., announced that the Company has signed a manufacturing agreement with Florida Biologix for the production of the sterile liquid form of its Trappsol Cyclo product, an orphan ... read more
Aesica Reaffirms Its Position as Leading Integrated CMO
Wednesday, February 22, 2012
Global pharmaceutical manufacturer, Aesica, experienced significant growth in 2011, doubling both its turnover and its workforce and forming a number of long-term strategic partnerships with customers such as UCB and Noramco. read more
Boehringer Ingelheim and Xencor Enter a Collaboration Agreement
Tuesday, February 21, 2012
Xencor, Inc., a company using its proprietary Protein Design Automation® (PDA) platform technology to engineer next-generation antibodies, and Boehringer Ingelheim announced today a collaboration agreement for certain Xencor biosuperior monoclonal ... read more
Bilcare Research Introduces BilcareOptima™
Tuesday, February 21, 2012
Service Eliminates Over-Packaging by Providing Deep Knowledge of a Product’s Stability Barrier Needs Before It Is Packaged . . . Leading to a “Just Right” Solution for Oral Dose Products in Six Weeks read more
Catalent Completes Acquisition of Clinical Trials Supplies Business of Aptuit LLC
Friday, February 17, 2012
Catalent Pharma Solutions today announced that it has completed the acquisition of the Clinical Trial Supplies business of Aptuit LLC. The acquisition substantially expands Catalent’s Development & Clinical Services business, transforming it into the... read more
Catalent Pharma Solutions And Newmarket Pharmaceuticals LLC Partner to Develop Better Treatments
Thursday, February 16, 2012
Catalent Pharma Solutions, a leading global drug delivery technology company, and NewMarket Pharmaceuticals LLC have entered into an agreement to jointly formulate and develop a portfolio of products for treating production and companion animals ... read more
Ockham Completes Acquisition of Nexus Oncology
Thursday, February 16, 2012
Ockham, a leading, global full-service contract research organization (CRO) with a focus in oncology, today announces it has completed the acquisition of Nexus Oncology. The transaction also provides Ockham with an institutional investment partner. read more
Cobra Biologics’ Expansion Continues
Monday, February 13, 2012
Cobra Biologics, the international clinical and commercial manufacturer of biologics and pharmaceuticals, announces the appointment of three non-executive directors to Cobra Biologics’ board, and two business development managers tasked with driving ... read more
One Year On…Almac Doubles Analytical Capacity in US Headquarters
Thursday, February 09, 2012
Almac is pleased to announce the doubling of analytical capacity at its 240,000 sq. ft. North American Headquarters. The facility, built on a 40 acre site in Souderton, PA, north of Philadelphia, and occupied since 2010, delivers full-service, ... read more
INC Research Releases New White Paper
Wednesday, February 08, 2012
INC Research , LLC, a therapeutically focused clinical research organization (CRO) with a trusted process for delivering reliable results, today announced it has released a new white paper titled, "The Innovation Imperative: How CROs Are Driving The... read more
Pharma and Biotech Services
Sunday, January 01, 2012
Bachem is a technology-based biochemicals company providing full service to the pharma and biotech industry. Bachem specializes in the manufacture of peptides and complex organic molecules as APIs, as well as innovative biochemicals for research ... read more